Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX

Hisse Senetlerindeki Sıralama #409

Bu şirket açıklaması yalnızca İngilizce olarak sunulmaktadır.

Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Hisse Fiyatı
$41.88
Son senkronizasyon: 2026-10-30
Piyasa Değeri
$60.69B
Değişim (1 gün)
-1.89%
Değişim (1 yıl)
-58.42%
Ülke
US

Hisse senedi verileri: Financial Modeling Prep·Güncelleme: ·Yatırım tavsiyesi değildir·Nasıl hesaplıyoruz

Kategori

Healthcare
Boston Scientific Corporation (BSX) için hisse bölünme geçmişi
Boston Scientific Corporation hissesi (sembol: BSX) toplamda 2 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Nov 06, 2003 tarihinde gerçekleşmiştir.
Dec 01, 1998 tarihinden önce alınan bir BSX hissesi bugün 4 BSX hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
2003-11-06 2:1 x2 x4
1998-12-01 2:1 x2 x2
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
9 x285
US
7 x127
IE
9 x162
US
0 -
DE
3 x12
US

Boston Scientific Corporation hisse bölünmeleri hakkında sorular

Boston Scientific Corporation kaç kez hisse bölünmesi yaptı?

Boston Scientific Corporation (BSX) bugüne kadar 2 kez hisse bölünmesi yaptı. İlk bölünme 1 Ara 1998 tarihinde, en sonuncusu ise 6 Kas 2003 tarihinde gerçekleşti.

1 Ara 1998 tarihinden önce alınan bir Boston Scientific Corporation hissesi bugün kaç hisseye karşılık geliyor?

Tüm hisse bölünmelerinden sonra, 1 Ara 1998 tarihinden önce alınan bir hisse bugün 4.00 hisseye karşılık geliyor.